ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2614

Plasma Of Active Behçet´s Disease Increases Oxidative Metabolism Profile Of Normal and Patients Phagocytes

Sandro F. Perazzio1,2, Paulo Vitor Soeiro Pereira3, Alexandre W.S. Souza4,5, Antonio Condino-Neto3 and Luis Eduardo C. Andrade6, 1Rheumatology, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, 2Fleury Medicine and Health, Sao Paulo, Brazil, 3Immunology, ICB IV - Universidade de São Paulo, São Paulo, Brazil, 4University Medical Center Groningen, Groningen, Netherlands, 5Rheumatology Div/Dept of Med, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, 6Rheumatology Division, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Autoinflammatory Disease, Behcet's syndrome and Redox Balance

  • Tweet
  • Email
  • Print
Session Information

Title: Vasculitis III

Session Type: Abstract Submissions (ACR)

Background/Purpose: Behçet’s disease (BD) exhibits several features suggestive of neutrophil hiperactivity. It is unclear whether neutrophil activation occurs constitutively or if it is secondary to yet unknown stimuli. Previous studies suggested a possible role for infectious agents and for unknown plasma factors in BD pathogenesis. The present study investigated the oxidative burst in phagocytes of patients with active BD (aBD) and inactive BD (iBD) in the presence of diverse stimuli.

Methods: Neutrophils and peripheral blood mononuclear cells (PBMC) were obtained from patients with aBD (n=30), iBD (n=31), septic patients (SP; n=25), and healthy controls (HC; n=30). BD activity was established as Behçet’s Disease Current Activity Form Simplified (BDCAFs) score≥2. Oxidative burst was assessed by dihidrorhodamine (DHR) oxidation before and after stimulation with phorbol myristate acetate (PMA) or human plasma (from HC or aBD). H2O2 and O2– production was determined in neutrophils and PBMC by luminol/lucigenin luminescence intensity with or without stimulation with PMA, Streptococcus pneumoniae, Streptococcus sanguinis, Candida albicans or human plasma.

Results:

There was no significant difference in medication use between aBD and iBD patients. Resting phagocytes from the four groups presented equivalent oxidative burst (DHR assay and H2O2/O2– production). However, aBD neutrophils produced more O2– when exposed to aBD plasma (median/range=96,297/19,202-298,941) compared to HC plasma (48,831/4,001-105,848; p=0.028) or non-stimulated (5,721/551-23,838; p<0.01). HC neutrophils also produced more O2– when stimulated by aBD plasma (93,452/12,242-226,932) versus HC plasma (36,225/8,432-79,461; p=0.028) versus non-stimulated (3,387/1,870-13,935, p<0.01). aBD neutrophils also produced more H2O2 when exposed to aBD plasma (404,045/24,825-1,408,347) compared to HC plasma (338,238/5,042-745,653; p=0.02) or non-stimulated (9,300/2,706-27,193; p<0.01). The same occurred with neutrophils from HC: aBD plasma (355,079/51,354-513,977); non-stimulated (15,092/4,959-47,814; p<0.01). PBMC from aBD produced more O2– when exposed to aBD plasma (39,208/9,656-315,306) compared to HC plasma (10,135/3,394-41,873; p=0.046) or non-stimulated (10,052/3,262-37,352; p=0.028). The same occurred with HC PBMC: 24,531/4,931-73,813; 3,661/1,697-28,992 (p=0.03); 1,994/928-5,532, respectively (p=0.02). Finally, H2O2 production in aBD PBMC was enhanced by aBD plasma (55,223/17,186-253,194) versus HC plasma (35,193/2,081-331,239; p=0.05) versus non-stimulated (18,690/2,340-78,728; p=0.046). The same was observed with HC PBMC: aBD plasma (10,357/4,024-75,036); HC plasma (2,502/975-7,810, p=0.028). H2O2 and O2– production after microbial stimuli was equivalent for phagocytes from aBD, iBD, and HC.

Conclusion: Phagocytes from BD patients were not constitutively activated and responded normally to microbial and PMA stimuli. Plasma from patients with active BD exerted a strong stimulus for H2O2 and O2– production. These findings warrant further studies in order to identify possible metabolic pathways involved in neutrophil activation in BD.


Disclosure:

S. F. Perazzio,
None;

P. V. S. Pereira,
None;

A. W. S. Souza,
None;

A. Condino-Neto,
None;

L. E. C. Andrade,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/plasma-of-active-behcets-disease-increases-oxidative-metabolism-profile-of-normal-and-patients-phagocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology